ArticleNature communications2021

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.

Samuel Rivero-Hinojosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.